Ebola Virus Glycoprotein Counteracts BST-2/Tetherin Restriction in a Sequence-Independent Manner That Does Not Require Tetherin Surface Removal
Open Access
- 15 July 2010
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (14), 7243-7255
- https://doi.org/10.1128/jvi.02636-09
Abstract
BST-2/tetherin is an interferon-inducible protein that restricts the release of enveloped viruses from the surface of infected cells by physically linking viral and cellular membranes. It is present at both the cell surface and in a perinuclear region, and viral anti-tetherin factors including HIV-1 Vpu and HIV-2 Env have been shown to decrease the cell surface population. To map the domains of human tetherin necessary for both virus restriction and sensitivity to viral anti-tetherin factors, we constructed a series of tetherin derivatives and assayed their activity. We found that the cytoplasmic tail (CT) and transmembrane (TM) domains of tetherin alone produced its characteristic cellular distribution, while the ectodomain of the protein, which includes a glycosylphosphatidylinositol (GPI) anchor, was sufficient to restrict virus release when presented by the CT/TM regions of a different type II membrane protein. To counteract tetherin restriction and remove it from the cell surface, HIV-1 Vpu required the specific sequence present in the TM domain of human tetherin. In contrast, the HIV-2 Env required only the ectodomain of the protein and was sensitive to a point mutation in this region. Strikingly, the anti-tetherin factor, Ebola virus GP, was able to overcome restriction conferred by both tetherin and a series of functional tetherin derivatives, including a wholly artificial tetherin molecule. Moreover, GP overcame restriction without significantly removing tetherin from the cell surface. These findings suggest that Ebola virus GP uses a novel mechanism to circumvent tetherin restriction.Keywords
This publication has 46 references indexed in Scilit:
- Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestrationProceedings of the National Academy of Sciences of the United States of America, 2009
- Antiviral Activity of the Interferon-Induced Cellular Protein BST-2/TetherinAIDS Research and Human Retroviruses, 2009
- HIV-1 Accessory Protein Vpu Internalizes Cell-surface BST-2/Tetherin through Transmembrane Interactions Leading to LysosomesPublished by Elsevier BV ,2009
- Tetherin-Driven Adaptation of Vpu and Nef Function and the Evolution of Pandemic and Nonpandemic HIV-1 StrainsCell Host & Microbe, 2009
- Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to CellsCell, 2009
- Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin AntagonistsCell Host & Microbe, 2009
- HM1.24 Is Internalized from Lipid Rafts by Clathrin-mediated Endocytosis through Interaction with α-AdaptinPublished by Elsevier BV ,2009
- Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletionProceedings of the National Academy of Sciences of the United States of America, 2009
- Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoproteinProceedings of the National Academy of Sciences of the United States of America, 2009
- The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu ProteinCell Host & Microbe, 2008